Variant report
Variant | nsv973833 |
---|---|
Chromosome Location | chr9:9383583-9388587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10977705 | chr9:9384826-9384827 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs10977706 | chr9:9384843-9384844 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs10977707 | chr9:9384848-9384849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs564730195 | chr9:9384865-9384866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114404221 | chr9:9384881-9384882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10977708 | chr9:9384933-9384934 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs10816106 | chr9:9384954-9384955 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs530769804 | chr9:9384971-9384972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553117923 | chr9:9384974-9384975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10816107 | chr9:9384983-9384984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs115312941 | chr9:9385002-9385003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376221691 | chr9:9385014-9385015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553743991 | chr9:9385024-9385025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs16929237 | chr9:9385077-9385078 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs188437825 | chr9:9385087-9385088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62532899 | chr9:9385107-9385108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562342006 | chr9:9385113-9385114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192382649 | chr9:9385146-9385147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574169011 | chr9:9385215-9385216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541100119 | chr9:9385232-9385233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559426681 | chr9:9385237-9385238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573588488 | chr9:9385249-9385250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551399797 | chr9:9385255-9385256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs150558761 | chr9:9385328-9385329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183242610 | chr9:9385350-9385351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10816108 | chr9:9385356-9385357 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs567419929 | chr9:9385360-9385361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186489641 | chr9:9385366-9385367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546670674 | chr9:9385381-9385382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1023217 | chr9:9385401-9385402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs372554593 | chr9:9385418-9385419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527452881 | chr9:9385420-9385421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191250187 | chr9:9385423-9385424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142140785 | chr9:9385437-9385438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537718935 | chr9:9385486-9385487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555810884 | chr9:9385488-9385489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184541086 | chr9:9385489-9385490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564752295 | chr9:9385490-9385491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10816109 | chr9:9385507-9385508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs151197548 | chr9:9385522-9385523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561014557 | chr9:9385536-9385537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10816110 | chr9:9385560-9385561 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs563732723 | chr9:9385583-9385584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140339403 | chr9:9385604-9385605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150218121 | chr9:9385610-9385611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561027318 | chr9:9385626-9385627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10977709 | chr9:9385640-9385641 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs10977710 | chr9:9385651-9385652 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs188179840 | chr9:9385656-9385657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532279664 | chr9:9385681-9385682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9384800-9385600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr9:9385200-9385600 | Enhancers | Stomach Mucosa | stomach |
3 | chr9:9385400-9385800 | Enhancers | Aorta | Aorta |
4 | chr9:9385600-9390800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
5 | chr9:9386800-9387200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr9:9387600-9387800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr9:9387800-9389600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |